ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesJ84.02

J84.02

Pulmonary alveolar microlithiasis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 J84.02 is a billable code used to indicate a diagnosis of pulmonary alveolar microlithiasis.

Key Diagnostic Point:

Pulmonary alveolar microlithiasis (PAM) is a rare lung disease characterized by the accumulation of microscopic calcium phosphate crystals within the alveoli, leading to respiratory dysfunction. Clinically, patients may present with symptoms such as progressive dyspnea, cough, and chest pain. The disease primarily affects the lung's alveolar spaces, which are crucial for gas exchange. As PAM progresses, it can lead to pulmonary fibrosis, resulting in decreased lung compliance and impaired oxygenation. Diagnosis typically involves imaging studies such as chest X-rays or CT scans, which reveal characteristic bilateral ground-glass opacities and micronodular patterns. A definitive diagnosis may require lung biopsy, where the microliths can be identified histologically. Given its rarity, PAM often poses diagnostic challenges, necessitating a high index of suspicion in patients presenting with unexplained respiratory symptoms. Early recognition and management are essential to mitigate complications and improve patient outcomes.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: The rarity of the condition can complicate diagnosis, requiring specialized imaging and possibly biopsy.
  • Treatment complexity: There is no specific treatment; management focuses on symptomatic relief and monitoring.
  • Documentation requirements: Detailed clinical documentation is necessary to support the diagnosis and treatment plan.
  • Coding specificity: Accurate coding requires understanding of the condition's nuances and differentiation from similar respiratory disorders.

Audit Risk Factors

  • Common coding errors: Misclassification with other interstitial lung diseases.
  • Documentation gaps: Insufficient clinical details to justify the diagnosis.
  • Billing challenges: Potential denials due to lack of clarity in the clinical rationale for testing and treatment.

Specialty Focus

Medical Specialties

Pulmonology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Pathology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Pulmonary alveolar microlithiasis, while rare, has significant clinical implications for affected individuals, leading to chronic respiratory issues and potential long-term disability. Understanding this condition is crucial for improving population health outcomes, as timely diagnosis and management can enhance quality of life and reduce healthcare utilization. Epidemiologically, PAM's rarity underscores the need for awareness among healthcare providers to facilitate early detection and appropriate care.

ICD-9 vs ICD-10

Pulmonary alveolar microlithiasis, while rare, has significant clinical implications for affected individuals, leading to chronic respiratory issues and potential long-term disability. Understanding this condition is crucial for improving population health outcomes, as timely diagnosis and management can enhance quality of life and reduce healthcare utilization. Epidemiologically, PAM's rarity underscores the need for awareness among healthcare providers to facilitate early detection and appropriate care.

Reimbursement & Billing Impact

Reimbursement may be affected by the rarity of the condition, necessitating thorough justification for imaging and treatment. Common denials may arise from insufficient documentation or misclassification of the condition. Best practices include ensuring that all clinical findings are well-documented and that the rationale for any diagnostic tests is clearly articulated in the medical record.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for J00-J99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for J00-J99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by J84.02?

J84.02 specifically covers pulmonary alveolar microlithiasis, a condition characterized by the accumulation of microliths in the alveoli, leading to respiratory symptoms and potential lung damage.

When should J84.02 be used instead of related codes?

J84.02 should be used when there is clear evidence of pulmonary alveolar microlithiasis, particularly when imaging and clinical findings support this diagnosis, differentiating it from other interstitial lung diseases.

What documentation supports J84.02?

Documentation should include clinical symptoms, imaging results showing characteristic findings, and any histopathological evidence from lung biopsies confirming the presence of microliths.